Article
<i>MYC–NFATC2 axis</i> maintains cell cycle and mitochondrial function in AML cells
2023-11-17
Abstract excerpt
Acute myeloid leukaemia (AML) is a clonal haematological malignancy affecting the myeloid lineage with generally poor patient outcomes, owing to the lack of targeted therapies. The histone lysine demethylase 4A (KDM4A) has been established as a novel therapeutic target in AML, due to its selective oncogenic role within leukaemic cells. We identify that the transcription factor NFATC2 is a novel binding and transc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d0f0077b-7f79-56b8-95f8-22ccae02e600
- DOI
- 10.1101/2023.11.15.567209
